Systemic antifungal therapy: Past, present and future

被引：23
作者：
Al-Mohsen, I [1 ]
Hughes, WT [1 ]
机构：
[1] NCI, Pediat Canc Branch, Bethesda, MD 20892 USA
来源：
ANNALS OF SAUDI MEDICINE | 1998年 / 18卷 / 01期
关键词：
D O I：
10.5144/0256-4947.1998.28
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：28 / 38
页数：11
相关论文
共 101 条
[81]   COMBINATION THERAPY OF MURINE INVASIVE CANDIDIASIS WITH FLUCONAZOLE AND AMPHOTERICIN-B [J].
SUGAR, AM ;
HITCHCOCK, CA ;
TROKE, PF ;
PICARD, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :598-601
[82]   USE OF AMPHOTERICIN-B WITH AZOLE ANTIFUNGAL DRUGS - WHAT ARE WE DOING [J].
SUGAR, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :1907-1912
[83]  
TROKE PF, 1990, REV INFECT DIS, V12, pS276
[84]  
VandeVelde VJS, 1996, PHARMACOTHERAPY, V16, P424
[85]   IN-VITRO ACTIVITY OF A NEW PNEUMOCANDIN ANTIFUNGAL AGENT, L-733,560, AGAINST AZOLE-SUSCEPTIBLE AND AZOLE-RESISTANT CANDIDA AND TORULOPSIS SPECIES [J].
VAZQUEZ, JA ;
LYNCH, M ;
SOBEL, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2689-2691
[86]  
VAZQUEZ JA, 1996, 36 ICAAC C
[87]  
Walsh T J, 1996, Adv Pediatr Infect Dis, V11, P187
[88]   MANAGEMENT OF IMMUNOCOMPROMISED PATIENTS WITH EVIDENCE OF AN INVASIVE MYCOSIS [J].
WALSH, TJ .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (05) :1003-1026
[89]   EXPERIMENTAL ANTIFUNGAL CHEMOTHERAPY IN GRANULOCYTOPENIC ANIMAL-MODELS OF DISSEMINATED CANDIDIASIS - APPROACHES TO UNDERSTANDING INVESTIGATIONAL ANTIFUNGAL COMPOUNDS FOR PATIENTS WITH NEOPLASTIC DISEASES [J].
WALSH, TJ ;
LEE, JW ;
ROILIDES, E ;
FRANCIS, P ;
BACHER, J ;
LYMAN, CA ;
PIZZO, PA .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S139-S147
[90]   Recent progress and current problems in treatment of invasive fungal infection sin neutropenic patients [J].
Walsh, TJ ;
Hiemenz, JW ;
Anaissie, E .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1996, 10 (02) :365-+
234567891011